{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:17:31Z","timestamp":1794565051161,"version":"4.9.1"},"reference-count":43,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010564","name":"Academic Medical Organization of Southwestern Ontario","doi-asserted-by":"publisher","award":["INN21-011"],"award-info":[{"award-number":["INN21-011"]}],"id":[{"id":"10.13039\/100010564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000023","name":"Government of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["Foundation Award"],"award-info":[{"award-number":["Foundation Award"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-21-0031455"],"award-info":[{"award-number":["G-21-0031455"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2024,7,3]]},"DOI":"10.1080\/17446651.2024.2365787","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T09:15:39Z","timestamp":1717751739000},"page":"299-306","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["Etiology and emerging treatments for familial chylomicronemia syndrome"],"prefix":"10.1080","volume":"19","author":[{"given":"Catherine M.","family":"Spagnuolo","sequence":"first","affiliation":[{"name":"Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2861-5325","authenticated-orcid":false,"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2022.2094768"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.17925\/EE.2022.18.2.82"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-023-01140-z"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.12997\/jla.2024.13.1.2"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13050621"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2023.01.005"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.06.814"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2012.08.007"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-022-01631-z"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab890"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2023.2206015"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000764"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000789"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.301464"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000502"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400284"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400283"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1715944"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2023.04.007"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00046-2"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2023.03.007"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.05.008"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2306575"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/14779072.2018.1487290"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab820"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2400201"},{"key":"e_1_3_4_29_1","unstructured":"A study of olezarsen administered subcutaneously to participants with severe hypertriglyceridemia. Clinicaltrials.gov. https:\/\/www.clinicaltrials.gov\/study\/NCT05552326"},{"key":"e_1_3_4_30_1","unstructured":"A study of ISIS 678354 administered to participants with severe hypertriglyceridemia. Clinicaltrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05079919"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2402309"},{"key":"e_1_3_4_32_1","unstructured":"A study of olezarsen (ISIS 678354) in participants with hypertriglyceridemia and atherosclerotic cardiovascular disease or with severe hypertriglyceridemia. Clinicaltrials.gov. https:\/\/www.clinicaltrials.gov\/study\/NCT05610280"},{"key":"e_1_3_4_33_1","unstructured":"Study of ARO-APOC3 in adults with familial chylomicronemia syndrome (FCS) (PALISADE). Clinicaltrials.gov. https:\/\/www.clinicaltrials.gov\/study\/NCT05089084"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200325"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2404143"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2024.0959"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae068"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612790"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa689"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.059266"},{"key":"e_1_3_4_41_1","unstructured":"Pfizer Inc. Ionis Pharmaceuticals Inc. Pfizer and Ionis announce discontinuation of vupanorsen clinical development program [Internet]. NY and Carlsbad (CA): Pfizer; 2022 Jan [cited 2024 Feb 24]. Available from: https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-ionis-announce-discontinuation-vupanorsen"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12010168"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02222-w"},{"key":"e_1_3_4_44_1","unstructured":"Regeneron Pharmaceuticals. Efficacy and safety of evinacumab in adult patients with severe hypertriglyceridemia for the prevention of recurrent acute pancreatitis. Clinicaltrials.gov; 2023. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04863014"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02494-2"}],"container-title":["Expert Review of Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17446651.2024.2365787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T11:38:23Z","timestamp":1733312303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17446651.2024.2365787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7,3]]}},"alternative-id":["10.1080\/17446651.2024.2365787"],"URL":"https:\/\/doi.org\/10.1080\/17446651.2024.2365787","relation":{},"ISSN":["1744-6651","1744-8417"],"issn-type":[{"value":"1744-6651","type":"print"},{"value":"1744-8417","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iere20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iere20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-03-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}